| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.5 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | -0.09 | 0.5 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.2 | 0.5 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.13 | 0.5 |